CORONA — Corona Remedies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹103.03bn
- IN₹104.23bn
- IN₹14.03bn
Annual cashflow statement for Corona Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 1,109 | 1,185 | 1,985 | 2,404 |
| Depreciation | ||||
| Non-Cash Items | 24.5 | 186 | 151 | 64.8 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -307 | -85.9 | -603 | -553 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | 1,027 | 1,568 | 1,905 | 2,295 |
| Capital Expenditures | -948 | -2,863 | -916 | -1,741 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 445 | 197 | 78.1 | -820 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -502 | -2,666 | -838 | -2,562 |
| Financing Cash Flow Items | -113 | -314 | -328 | -521 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -447 | 985 | -1,066 | 253 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 76.7 | -113 | 0.67 | -13.9 |